PDB Short entry for 2FB8 HEADER TRANSFERASE 08-DEC-05 2FB8 TITLE STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885 COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: B-RAF KINASE DOMAIN, RESIDUES 445-723; COMPND 5 SYNONYM: P94, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF-9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PACGP67 KEYWDS KINASE DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.LOUGHEED,J.LEE,D.C.CHAU,T.J.STOUT REVDAT 3 14-FEB-24 2FB8 1 REMARK SEQADV REVDAT 2 24-FEB-09 2FB8 1 VERSN REVDAT 1 12-DEC-06 2FB8 0 JRNL AUTH A.J.KING,D.R.PATRICK,R.S.BATORSKY,M.L.HO,H.T.DO,S.Y.ZHANG, JRNL AUTH 2 R.KUMAR,D.W.RUSNAK,A.K.TAKLE,D.M.WILSON,E.HUGGER,L.WANG, JRNL AUTH 3 F.KARRETH,J.C.LOUGHEED,J.LEE,D.CHAU,T.J.STOUT,E.W.MAY, JRNL AUTH 4 C.M.ROMINGER,M.D.SCHABER,L.LUO,A.S.LAKDAWALA,J.L.ADAMS, JRNL AUTH 5 R.G.CONTRACTOR,K.S.SMALLEY,M.HERLYN,M.M.MORRISSEY, JRNL AUTH 6 D.A.TUVESON,P.S.HUANG JRNL TITL DEMONSTRATION OF A GENETIC THERAPEUTIC INDEX FOR TUMORS JRNL TITL 2 EXPRESSING ONCOGENIC BRAF BY THE KINASE INHIBITOR SB-590885. JRNL REF CANCER RES. V. 66 11100 2006 JRNL REFN ISSN 0008-5472 JRNL PMID 17145850 JRNL DOI 10.1158/0008-5472.CAN-06-2554 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 16653 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 840 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1104 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.84 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4134 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.39000 REMARK 3 B22 (A**2) : -0.39000 REMARK 3 B33 (A**2) : 0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.448 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.338 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.667 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.907 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.797 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4298 ; 0.020 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5804 ; 2.219 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 8.557 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;38.731 ;23.804 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 778 ;21.266 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;21.658 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 636 ; 0.130 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3192 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2266 ; 0.276 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2913 ; 0.342 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 195 ; 0.184 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.230 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2643 ; 0.888 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4162 ; 1.595 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1897 ; 1.947 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1642 ; 3.132 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2FB8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000035675. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 46.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.22700 REMARK 200 R SYM (I) : 0.22700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 2.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.48900 REMARK 200 R SYM FOR SHELL (I) : 0.48900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG 8000, 0.4 M LICL, 0.1 M TRIS, REMARK 280 0.02 M BIS-TRIS PROPANE, 15% GLYCEROL, 1 MM DTT, PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 18K, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.61100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.81900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.81900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.80550 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.81900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.81900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 119.41650 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.81900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.81900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.80550 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.81900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.81900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 119.41650 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.61100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 443 REMARK 465 SER A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 LEU A 721 REMARK 465 PRO A 722 REMARK 465 LYS A 723 REMARK 465 GLY B 443 REMARK 465 SER B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ASP B 448 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 632 C - N - CA ANGL. DEV. = 10.8 DEGREES REMARK 500 ARG B 509 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 PRO B 632 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 PRO B 705 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 453 127.64 -36.46 REMARK 500 SER A 467 -49.29 -151.87 REMARK 500 TRP A 476 97.97 -163.24 REMARK 500 ASN A 486 -88.90 21.28 REMARK 500 VAL A 487 97.04 3.53 REMARK 500 ALA A 489 100.21 48.55 REMARK 500 ARG A 509 105.70 -160.88 REMARK 500 HIS A 510 125.30 176.19 REMARK 500 ASN A 512 5.60 -64.85 REMARK 500 ILE A 543 -74.08 -91.02 REMARK 500 GLU A 545 78.23 1.31 REMARK 500 THR A 546 98.40 -64.95 REMARK 500 LYS A 547 109.26 -43.71 REMARK 500 ASP A 576 37.17 -163.53 REMARK 500 ASP A 587 -15.22 44.14 REMARK 500 ASP A 594 94.56 62.65 REMARK 500 THR A 599 -160.39 -174.72 REMARK 500 MET A 627 28.49 37.99 REMARK 500 ASP A 629 141.31 57.18 REMARK 500 LYS A 630 -38.00 -36.22 REMARK 500 ARG A 662 -71.45 -29.14 REMARK 500 ASP A 663 -48.97 -25.28 REMARK 500 ARG A 682 134.08 -29.02 REMARK 500 ASN A 684 -11.87 -39.37 REMARK 500 ARG A 701 -77.54 -13.03 REMARK 500 LEU A 716 -73.84 -60.43 REMARK 500 SER B 467 -70.13 167.35 REMARK 500 ASP B 479 127.11 -39.10 REMARK 500 ASN B 486 -47.94 72.22 REMARK 500 VAL B 487 150.36 -32.83 REMARK 500 ALA B 489 102.83 69.52 REMARK 500 ARG B 506 -28.34 -39.42 REMARK 500 ARG B 509 99.30 -161.24 REMARK 500 HIS B 510 120.35 -170.48 REMARK 500 VAL B 511 -34.25 -34.20 REMARK 500 LEU B 514 113.73 -19.11 REMARK 500 THR B 521 -73.73 -129.65 REMARK 500 GLN B 530 139.51 -39.57 REMARK 500 GLU B 549 153.67 -46.19 REMARK 500 ARG B 575 -5.57 71.94 REMARK 500 ASP B 576 37.02 -140.71 REMARK 500 SER B 579 3.20 -66.76 REMARK 500 GLU B 586 50.55 26.44 REMARK 500 ASP B 587 5.24 43.07 REMARK 500 ASP B 594 91.89 45.12 REMARK 500 PHE B 595 30.47 -99.34 REMARK 500 MET B 627 63.09 78.80 REMARK 500 ASP B 629 -159.84 18.72 REMARK 500 ASN B 661 64.24 -165.45 REMARK 500 ARG B 662 -73.76 -12.73 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 532 GLU A 533 149.69 REMARK 500 SER A 614 GLY A 615 -148.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 215 B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 215 A 102 DBREF 2FB8 A 445 723 UNP P15056 BRAF1_HUMAN 445 723 DBREF 2FB8 B 445 723 UNP P15056 BRAF1_HUMAN 445 723 SEQADV 2FB8 GLY A 443 UNP P15056 CLONING ARTIFACT SEQADV 2FB8 SER A 444 UNP P15056 CLONING ARTIFACT SEQADV 2FB8 GLY B 443 UNP P15056 CLONING ARTIFACT SEQADV 2FB8 SER B 444 UNP P15056 CLONING ARTIFACT SEQRES 1 A 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 281 LEU LEU ALA ARG SER LEU PRO LYS SEQRES 1 B 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 281 LEU LEU ALA ARG SER LEU PRO LYS HET 215 A 102 34 HET 215 B 101 34 HETNAM 215 (1Z)-5-(2-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5- HETNAM 2 215 PYRIDIN-4-YL-1H-IMIDAZOL-4-YL)INDAN-1-ONE OXIME FORMUL 3 215 2(C27 H27 N5 O2) FORMUL 5 HOH *36(H2 O) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 LEU A 537 ILE A 543 1 7 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 SER A 616 MET A 620 5 5 HELIX 5 5 ALA A 621 ARG A 626 1 6 HELIX 6 6 SER A 634 MET A 650 1 17 HELIX 7 7 ASN A 661 ARG A 671 1 11 HELIX 8 8 ASP A 677 VAL A 681 5 5 HELIX 9 9 PRO A 686 LYS A 698 1 13 HELIX 10 10 LYS A 700 ARG A 704 5 5 HELIX 11 11 LEU A 706 ARG A 719 1 14 HELIX 12 12 THR B 491 ARG B 506 1 16 HELIX 13 13 SER B 536 ILE B 543 1 8 HELIX 14 14 GLU B 549 ALA B 569 1 21 HELIX 15 15 GLU B 586 LEU B 588 5 3 HELIX 16 16 SER B 616 MET B 620 5 5 HELIX 17 17 ALA B 621 MET B 627 1 7 HELIX 18 18 SER B 634 GLY B 652 1 19 HELIX 19 19 ASN B 661 ARG B 671 1 11 HELIX 20 20 PRO B 686 LEU B 697 1 12 HELIX 21 21 LYS B 700 ARG B 704 5 5 HELIX 22 22 LEU B 706 SER B 720 1 15 SHEET 1 A 5 THR A 458 SER A 465 0 SHEET 2 A 5 THR A 470 LYS A 475 -1 O LYS A 473 N GLY A 460 SHEET 3 A 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 A 5 PHE A 516 SER A 520 -1 N SER A 520 O ALA A 526 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 5 THR B 458 SER B 465 0 SHEET 2 C 5 THR B 470 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 C 5 ASP B 479 MET B 484 -1 O MET B 484 N THR B 470 SHEET 4 C 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 C 5 PHE B 516 SER B 520 -1 N MET B 517 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O THR B 589 N HIS B 585 CISPEP 1 LYS A 522 PRO A 523 0 18.96 CISPEP 2 LYS B 522 PRO B 523 0 6.74 SITE 1 AC1 12 TYR A 673 ALA B 481 LYS B 483 GLU B 501 SITE 2 AC1 12 THR B 529 TRP B 531 CYS B 532 TYR B 538 SITE 3 AC1 12 ILE B 543 PHE B 583 ASP B 594 ASN B 661 SITE 1 AC2 10 ILE A 463 GLY A 464 VAL A 471 ALA A 481 SITE 2 AC2 10 LYS A 483 GLU A 501 THR A 529 CYS A 532 SITE 3 AC2 10 PHE A 583 ASP A 594 CRYST1 95.638 95.638 159.222 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010456 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006281 0.00000